Expected results from clinical study
Eurocine Vaccines expect to present the results from the ongoing PhaseI/II study with the the first product candidate Immunose™ FLU.Read More
World Vaccine Congress 2017, Barcelona
Eurocine Vaccines will be in place to meet vaccine professionals from industry, academia, non-profit organizations and government to discuss challenges and successes but also presentRead…